<DOC>
	<DOCNO>NCT00175851</DOCNO>
	<brief_summary>This safety efficacy study add-on therapy seletracetam epilepsy patient participate previous seletracetam study</brief_summary>
	<brief_title>Open Label Trial Study Long-term Safety Efficacy Seletracetam Treatment Epilepsy</brief_title>
	<detailed_description />
	<mesh_term>Epilepsy</mesh_term>
	<criteria>A sign dated IRB/IEC approve write informed consent form Male/female age 18 year ( 16 year permit ) 65 year Minimum body weight 40 kg Patients participate previous seletracetam study Female patient without childbearing potential use medically accept nonhormonal contraceptive method eligible . Ongoing psychiatric disease mild control disorder Subject clinically significant abnormality laboratory test ECG Poor compliance visit schedule medication intake previous seletracetam study Subject take part another clinical/pharmacological study , exception seletracetam study , 30 day precede enrollment</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2012</verification_date>
	<keyword>Partial onset , primary generalize seizure , seletracetam</keyword>
</DOC>